HDAC6 and inflammatory breast carcinoma: A study in which IBC tumour cells were screened for loss of gene function via RNA interference technology identified HDAC6 as an essential gene for maintaining IBC tumour cell viability, and an inhibitor of HDAC6 was found to be effective in controlling the value added to IBC tumour cells in a preclinical model [74].